At CliniRx Research Pvt. Ltd., I authored and reviewed Statistical Analysis Plans for Phase II, Phase III, and open-label psychiatric trials. I also contributed to sample-size calculations and randomization plans for a Phase III trial.
I developed TLFs for safety and efficacy reporting and performed missing-data analyses, including multiple imputation and tipping-point sensitivity analysis. I used SAS for statistical programming and R to manipulate data and validate model outputs.
I reviewed Clinical Study Reports to check the interpretation of statistical outputs and worked with medical writing and clinical data management teams on regulatory submissions. My areas of interest include respiratory, oncology, and diabetes trials, survival analysis, and missing-data analysis.

